BOOM-IBD2 Pivotal Trial
Ulcerative Colitis (Inflammatory Bowel Disease)
PivotalActive
Key Facts
Indication
Ulcerative Colitis (Inflammatory Bowel Disease)
Phase
Pivotal
Status
Active
Company
About Boomerang Medical
Boomerang Medical is a clinical-stage medical device company pioneering a bioelectric neuromodulation therapy for autoimmune conditions, with an initial focus on Inflammatory Bowel Disease (IBD). Its lead technology has secured FDA Breakthrough Device Designation for Crohn's and ulcerative colitis and is currently being evaluated in an FDA-approved pivotal trial (BOOM-IBD2). The company is backed by leading venture capital firms, led by an experienced executive team with deep medtech expertise, and is positioned at the convergence of neurology and immunology within the emerging field of bioelectronic medicine.
View full company profileTherapeutic Areas
Other Ulcerative Colitis (Inflammatory Bowel Disease) Drugs
| Drug | Company | Phase |
|---|---|---|
| TP-317 | Thetis Pharmaceuticals | Phase 1b |